Please login to the form below

Not currently logged in
Email:
Password:

Antidepressant blocks tamoxifen benefits

Research shows the antidepressant paroxetine can interefere with the effectiveness of the breast cancer drug tamoxifen

Research published in the British Medical Journal (BMJ) shows that the antidepressant paroxetine can interefere with the effectiveness of the breast cancer drug tamoxifen.

Tamoxifen significantly improves survival in breast cancer. However, the drug works when the liver converts tamoxifen into an active metabolite (endoxifen). Paroxetine is a member of the selective serotonin reuptake inhibitor (SSRI) class of drugs, which inhibit the metabolic step that converts tamoxifen to endoxifen.

These findings are significant as many women with breast cancer are prescribed antidepressants – often for long periods of time.

The researchers examined the healthcare records of 2,430 women aged 66 years or older with breast cancer who received tamoxifen between 1993 and 2005. Around 30 per cent of these women also received an antidepressant at some time during their treatment with tamoxifen, with paroxetine being the most commonly used agent.

The results showed that use of paroxetine, but not other SSRIs, in combination with tamoxifen, was associated with an increased long-term risk of breast cancer death.

"Our findings indicate that the choice of antidepressant can significantly influence survival in women receiving tamoxifen for breast cancer," says Dr David Juurlink, one of the study's authors and a scientist at the Institute for Clinical Evaluative Sciences (ICES).

"This observation is consistent with what we know about tamoxifen's metabolism. These results highlight a drug interaction that is extremely common, widely under appreciated and potentially life-threatening, yet uniformly avoidable."

However, the study's authors stressed that patients should not stop taking tamoxifen.

 

10th February 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics